<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02402881</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00057117</org_study_id>
    <nct_id>NCT02402881</nct_id>
  </id_info>
  <brief_title>Education Bundle to Decrease Patient Refusal of VTE Prophylaxis</brief_title>
  <official_title>Patient-Centered Education Bundle to Decrease Patient Refusal of Venous Thromboembolism (VTE) Prophylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have recently developed a registry of missed doses of VTE prophylaxis that
      includes retrospective data on missed doses of VTE prophylaxis. To decrease rates of VTE
      prophylaxis refusal, the group has developed a patient-centered education bundle that will be
      delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting
      education materials include a 2-page education sheet and an educational video.

      The investigators hypothesize that patient refusal of VTE prophylaxis is associated with
      significant knowledge gaps among patients regarding patients' risk of developing VTE and the
      benefits of VTE prophylaxis and that delivering an education bundle to patients that refuse
      VTE prophylaxis will improve compliance with VTE prophylaxis and decrease rates of VTE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      This research group's published pilot study reported that nearly 12% of prescribed doses of
      pharmacologic VTE prophylaxis are not administered and almost 60% of missed doses are due to
      patient or family member refusal. Fanikos et al found that 44% of missed doses of VTE
      prophylaxis were due to patient refusal. In a survey of 500 recently hospitalized patients,
      the National Blood Clot Alliance found that only 28% and 15% respectively had basic knowledge
      of deep venous thrombosis (DVT) or pulmonary embolism (PE) despite the fact that 15% of
      participants had a history and 43% had a family history of either condition.

      Given these high rates of patient refusal of VTE prophylaxis and significant knowledge gaps
      regarding VTE, there is an urgent need to educate patients and families on the importance and
      benefits of compliance with VTE prophylaxis.

      The proposed patient-centered education bundle will be delivered as an in-person, 1-on-1
      discussion session with a nurse educator. Supporting education materials include a 2-page
      education sheet and an educational video.

      The investigators hypothesize that patient refusal of VTE prophylaxis is associated with
      significant knowledge gaps among patients regarding patients' risk of developing VTE and the
      benefits of VTE prophylaxis and that delivering an education bundle to patients that refuse
      VTE prophylaxis will improve compliance with VTE prophylaxis and decrease rates of VTE.

      Objectives

      Primary objective: is to determine the impact of delivering a patient education intervention
      bundle on rates of VTE prophylaxis non-administration.

      Secondary objective: is to determine the impact of delivering a patient education
      intervention bundle on rates of VTE.

      Methods

      The investigators have developed a real-time alert that notifies a member of the research
      team whenever a patient misses patients' dose of VTE prophylaxis. This interventional study
      will take place on on four hospital floors. Whenever a nurse educator receives an alert from
      any of the included floors indicating that a dose of VTE prophylaxis has been missed, she/he
      will visit the floor, and approach the nurse in charge of that patient to find out the reason
      for the missed dose. If the dose was missed as a result of patient refusal, the nurse
      educator will visit the patient and deliver the education bundle comprised of: 1) a
      one-on-one education session, 2) the patient education sheet and 3) the patient education
      video depending on patient preference. The intervention will be in real time for doses missed
      on business days between 8.00am and 4.00pm and at the start of the next business day for
      doses missed during non-business hours or on weekends. The investigators anticipate that the
      study will continue for 5 years and the investigators anticipate a total of 1000 patients
      during the study duration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">November 2018</completion_date>
  <primary_completion_date type="Actual">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Non Administration of Prescribed VTE Prophylaxis Medication Doses</measure>
    <time_frame>15 Months</time_frame>
    <description>This is the percentage of venous thromboembolism (VTE) prophylaxis doses that were not administered for any reason as documented in the electronic health record by a nurse.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Venous Thromboembolism</measure>
    <time_frame>15 Months</time_frame>
    <description>This is the number of participants with VTE events as documented in the electronic health record.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19652</enrollment>
  <condition>Venous Thromboembolism</condition>
  <condition>Deep Venous Thrombosis</condition>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive only the standard practices of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient-centered education bundle</intervention_name>
    <description>A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients on the four trial floors who miss at least one dose of VTE prophylaxis
             will be included in the study.

        Exclusion Criteria:

          -  N/A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elliott R Haut, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Medical Institutions</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pcori.org/research-in-action/improving-patient-nurse-communication-prevent-life-threatening-complication</url>
    <description>PCORI Website Page - &quot;Improving Patient-Nurse Communication to Prevent a Life-Threatening Complication&quot;</description>
  </link>
  <link>
    <url>http://www.pcori.org/research-results/2013/preventing-venous-thromboembolism-empowering-patients-and-enabling-patient</url>
    <description>PCORI Website Page - &quot;Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology&quot;</description>
  </link>
  <link>
    <url>http://www.hopkinsmedicine.org/armstrong/bloodclots</url>
    <description>The Johns Hopkins Armstrong Institute for Patient Safety and Quality Website &quot;Preventing Venous Thromboembolism&quot;</description>
  </link>
  <reference>
    <citation>Shermock KM, Lau BD, Haut ER, Hobson DB, Ganetsky VS, Kraus PS, Efird LE, Lehmann CU, Pinto BL, Ross PA, Streiff MB. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. PLoS One. 2013 Jun 14;8(6):e66311. doi: 10.1371/journal.pone.0066311. Print 2013. Review.</citation>
    <PMID>23799091</PMID>
  </reference>
  <reference>
    <citation>Fanikos J, Stevens LA, Labreche M, Piazza G, Catapane E, Novack L, Goldhaber SZ. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med. 2010 Jun;123(6):536-41. doi: 10.1016/j.amjmed.2009.11.017.</citation>
    <PMID>20569760</PMID>
  </reference>
  <reference>
    <citation>Maynard GA, Varga EA, Friedman RJ, Brownstein AP, Ansell JE. Deep vein thrombosis and pulmonary embolism: Awareness and prophylaxis practices reported by recently hospitalized patients. Society of Hospital Medicine Annual Meeting. 2011</citation>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>March 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <results_first_submitted>December 9, 2019</results_first_submitted>
  <results_first_submitted_qc>December 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 6, 2020</results_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>venous thromboembolism</keyword>
  <keyword>deep venous thrombosis</keyword>
  <keyword>pulmonary embolism</keyword>
  <keyword>blood clots</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 10, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT02402881/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>16 medical and surgical hospital units were included, intensive care units were excluded. Convenience sample of 4 units (2 surgical and 2 medical) received the intervention. The remaining 12 units (5 surgical and 7 medical) served as control and received no intervention. Pre-Intervention data were retrospectively assessed</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Patient-centered education bundle: A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients will receive only the standard practices of care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-Intervention Study Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2222"/>
                <participants group_id="P2" count="5657"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2222"/>
                <participants group_id="P2" count="5657"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-Intervention Study Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3111"/>
                <participants group_id="P2" count="8662"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3111"/>
                <participants group_id="P2" count="8662"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Patient Visits received the Patient-centered education bundle: A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.
This trial treats each visit as a separate enrollment and as a result it is only appropriate to consider the participant at the visit level. The outcomes assessed for this trial were analyzed on the patient visit level, as each visit represents a totally unique participant outcome. For example, Patient A might receive all doses during the first admission to the hospital but the same Patient A might miss doses during a second hospitalization. Similarly, Patient A might have been in Arm 1 during the first hospitalization and in Arm 2 during the second hospitalization.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patient Visits received the only the standard practices of care. This trial treats each visit as a separate enrollment and as a result it is only appropriate to consider the participant at the visit level. The outcomes assessed for this trial were analyzed on the patient visit level, as each visit represents a totally unique participant outcome. For example, Patient A might receive all doses during the first admission to the hospital but the same Patient A might miss doses during a second hospitalization. Similarly, Patient A might have been in Arm 1 during the first hospitalization and in Arm 2 during the second hospitalization.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5333"/>
            <count group_id="B2" value="14319"/>
            <count group_id="B3" value="19652"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2222"/>
                    <count group_id="B2" value="5657"/>
                    <count group_id="B3" value="7879"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.9" spread="17.4"/>
                    <measurement group_id="B2" value="56.3" spread="16.9"/>
                    <measurement group_id="B3" value="55.6" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3111"/>
                    <count group_id="B2" value="8662"/>
                    <count group_id="B3" value="11773"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.6" spread="17.6"/>
                    <measurement group_id="B2" value="55.8" spread="16.9"/>
                    <measurement group_id="B3" value="55.5" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2222"/>
                    <count group_id="B2" value="5657"/>
                    <count group_id="B3" value="7879"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1153"/>
                    <measurement group_id="B2" value="2687"/>
                    <measurement group_id="B3" value="3840"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1069"/>
                    <measurement group_id="B2" value="2970"/>
                    <measurement group_id="B3" value="4039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3111"/>
                    <count group_id="B2" value="8662"/>
                    <count group_id="B3" value="11773"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1587"/>
                    <measurement group_id="B2" value="4074"/>
                    <measurement group_id="B3" value="5661"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1524"/>
                    <measurement group_id="B2" value="4588"/>
                    <measurement group_id="B3" value="6112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2222"/>
                    <count group_id="B2" value="5657"/>
                    <count group_id="B3" value="7879"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="941"/>
                    <measurement group_id="B2" value="2307"/>
                    <measurement group_id="B3" value="3248"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1088"/>
                    <measurement group_id="B2" value="2850"/>
                    <measurement group_id="B3" value="3938"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="161"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Others</title>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="371"/>
                    <measurement group_id="B3" value="511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3111"/>
                    <count group_id="B2" value="8662"/>
                    <count group_id="B3" value="11773"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1308"/>
                    <measurement group_id="B2" value="3469"/>
                    <measurement group_id="B3" value="4777"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1533"/>
                    <measurement group_id="B2" value="4432"/>
                    <measurement group_id="B3" value="5965"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="167"/>
                    <measurement group_id="B3" value="240"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Others</title>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                    <measurement group_id="B2" value="580"/>
                    <measurement group_id="B3" value="773"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hospital Unit Type</title>
          <description>This refers to the unit of hospital where participants were seen; either surgical or medical units.</description>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2222"/>
                    <count group_id="B2" value="5657"/>
                    <count group_id="B3" value="7879"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Surgical</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1155"/>
                    <measurement group_id="B2" value="2530"/>
                    <measurement group_id="B3" value="3685"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Medical</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1067"/>
                    <measurement group_id="B2" value="3127"/>
                    <measurement group_id="B3" value="4194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3111"/>
                    <count group_id="B2" value="8662"/>
                    <count group_id="B3" value="11773"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Surgical</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1647"/>
                    <measurement group_id="B2" value="4076"/>
                    <measurement group_id="B3" value="5723"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Medical</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1464"/>
                    <measurement group_id="B2" value="4586"/>
                    <measurement group_id="B3" value="6050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Non Administration of Prescribed VTE Prophylaxis Medication Doses</title>
        <description>This is the percentage of venous thromboembolism (VTE) prophylaxis doses that were not administered for any reason as documented in the electronic health record by a nurse.</description>
        <time_frame>15 Months</time_frame>
        <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Patient-centered education bundle: A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will receive only the standard practices of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Non Administration of Prescribed VTE Prophylaxis Medication Doses</title>
          <description>This is the percentage of venous thromboembolism (VTE) prophylaxis doses that were not administered for any reason as documented in the electronic health record by a nurse.</description>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Percentage of nonadministration</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5333"/>
                <count group_id="O2" value="14319"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2222"/>
                    <count group_id="O2" value="5657"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" lower_limit="5.2" upper_limit="16.2"/>
                    <measurement group_id="O2" value="13.6" lower_limit="9.8" upper_limit="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3111"/>
                    <count group_id="O2" value="8662"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="3.1" upper_limit="9.9"/>
                    <measurement group_id="O2" value="13.3" lower_limit="9.6" upper_limit="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Our primary outcome was the proportion of non-administered doses of prescribed pharmacologic VTE prophylaxis. We compared rates of VTE prophylaxis non-administration pre-post-intervention. For estimating conditional odds ratios (ORs) and their 95% confidence intervals (CIs), the binomial family and a logit link were used; for estimating the conditional proportions, the Poisson family and a log link were used.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>We used generalized linear mixed-effects models with multiple outputation reiterated 1000 times to bootstrap the 95% CIs and the P values.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Venous Thromboembolism</title>
        <description>This is the number of participants with VTE events as documented in the electronic health record.</description>
        <time_frame>15 Months</time_frame>
        <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Patient-centered education bundle: A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will receive only the standard practices of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Venous Thromboembolism</title>
          <description>This is the number of participants with VTE events as documented in the electronic health record.</description>
          <population>Each row represents a different period of the study (pre intervention and post intervention) with different number of participants. Overall number of participants represents the number of unique patients in the study. These numbers reflect patient visits at baseline and following the implementation of the patient education intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5333"/>
                <count group_id="O2" value="14319"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2222"/>
                    <count group_id="O2" value="5657"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3111"/>
                    <count group_id="O2" value="8662"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Our secondary outcome was the proportion of VTE events. We compared rates of VTE prophylaxis nonadministration pre-post-intervention. For estimating conditional odds ratios (ORs) and their 95% CIs, the binomial family and a logit link were used; for estimating the conditional proportions, the Poisson family and a log link were used.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>We used generalized linear mixed-effects models with multiple outputation reiterated 1000 times to bootstrap the 95% CIs and the P values.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>15 Months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Patient Visits received the Patient-centered education bundle: A patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page patient education sheet and a patient education video.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patient Visits received only the standard practices of care.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5333"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14319"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5333"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14319"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5333"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14319"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elliott R Haut, MD PhD</name_or_title>
      <organization>The Johns Hopkins University</organization>
      <phone>410‑502‑3122</phone>
      <email>ehaut1@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

